2,4-thiazolidinedione has been researched along with Diseases, Metabolic in 2 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burris, TP | 1 |
| Busby, SA | 1 |
| Griffin, PR | 1 |
| Currier, JS | 1 |
1 review available for 2,4-thiazolidinedione and Diseases, Metabolic
| Article | Year |
|---|---|
Targeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunity.
Topics: Autoimmune Diseases; Humans; Metabolic Diseases; Orphan Nuclear Receptors; Phosphatidylcholines; PPA | 2012 |
1 other study available for 2,4-thiazolidinedione and Diseases, Metabolic
| Article | Year |
|---|---|
How to manage metabolic complications of HIV therapy: what to do while we wait for answers.
Topics: Anabolic Agents; Anti-HIV Agents; Anticholesteremic Agents; Atorvastatin; Exercise Therapy; Gemfibro | 2000 |